DK0863880T3 - Nye, anti-konvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som indeholder en disubstitueret aminrest i 4-stilling, og fremgangsmåde til deres fremstilling - Google Patents

Nye, anti-konvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som indeholder en disubstitueret aminrest i 4-stilling, og fremgangsmåde til deres fremstilling

Info

Publication number
DK0863880T3
DK0863880T3 DK96927607T DK96927607T DK0863880T3 DK 0863880 T3 DK0863880 T3 DK 0863880T3 DK 96927607 T DK96927607 T DK 96927607T DK 96927607 T DK96927607 T DK 96927607T DK 0863880 T3 DK0863880 T3 DK 0863880T3
Authority
DK
Denmark
Prior art keywords
convulsant
imidazolin
alk
acting
preparation
Prior art date
Application number
DK96927607T
Other languages
Danish (da)
English (en)
Inventor
Manfred Menzer
Karl Gewald
Harry Schaefer
Hans-Joachim Lankau
Klaus Unverferth
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0863880(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elbion Ag filed Critical Elbion Ag
Application granted granted Critical
Publication of DK0863880T3 publication Critical patent/DK0863880T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK96927607T 1995-09-05 1996-07-26 Nye, anti-konvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som indeholder en disubstitueret aminrest i 4-stilling, og fremgangsmåde til deres fremstilling DK0863880T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (de) 1995-09-05 1995-09-05 Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
PCT/EP1996/003295 WO1997009314A1 (de) 1995-09-05 1996-07-26 Neue, antikonvulsiv wirkende 1-ar(alk)yl-imidazolin-2-one, die in 4-stellung einen disubstituierten amin-rest enthalten, und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
DK0863880T3 true DK0863880T3 (da) 2004-03-22

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96927607T DK0863880T3 (da) 1995-09-05 1996-07-26 Nye, anti-konvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som indeholder en disubstitueret aminrest i 4-stilling, og fremgangsmåde til deres fremstilling

Country Status (31)

Country Link
EP (1) EP0863880B1 (enExample)
JP (1) JP4030578B2 (enExample)
CN (1) CN1103762C (enExample)
AR (1) AR003502A1 (enExample)
AT (1) ATE254606T1 (enExample)
AU (1) AU700602B2 (enExample)
BG (1) BG63917B1 (enExample)
BR (1) BR9610359A (enExample)
CA (1) CA2184871C (enExample)
CZ (1) CZ291839B6 (enExample)
DE (2) DE19532668A1 (enExample)
DK (1) DK0863880T3 (enExample)
EA (1) EA000535B1 (enExample)
EE (1) EE03562B1 (enExample)
ES (1) ES2208758T3 (enExample)
FR (1) FR13C0049I2 (enExample)
GE (1) GEP20022652B (enExample)
HU (1) HU225956B1 (enExample)
IL (1) IL123333A (enExample)
LT (1) LT4482B (enExample)
LU (1) LU92263I2 (enExample)
NO (1) NO313829B1 (enExample)
NZ (1) NZ315624A (enExample)
PL (1) PL188287B1 (enExample)
PT (1) PT863880E (enExample)
SK (1) SK284868B6 (enExample)
TR (1) TR199800476T1 (enExample)
TW (1) TW422838B (enExample)
UA (1) UA46790C2 (enExample)
WO (1) WO1997009314A1 (enExample)
ZA (1) ZA967014B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (de) * 1997-05-23 1998-11-26 Dresden Arzneimittel Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
AU2004255414A1 (en) * 2003-07-11 2005-01-20 Boehringer Ingelheim Vetmedica Gmbh Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
KR20140057604A (ko) 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina
EP4553066A1 (en) 2023-11-10 2025-05-14 Justesa Imagen S.A.U. Improved process for the synthesis of imepitoin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (fr) 1971-10-21 1973-04-20 American Cyanamid Co Nouvelles (p-chloro) phenyl-1 methyl-3 imidazolidines, 2,4-disubstituees utiles notamment comme agents diuretiques antialdosterone et leur procede de preparation
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
TR199800476T1 (xx) 1998-06-22
BG63917B1 (bg) 2003-06-30
EE03562B1 (et) 2001-12-17
ATE254606T1 (de) 2003-12-15
MX9801742A (es) 1998-08-30
CN1103762C (zh) 2003-03-26
LU92263I2 (fr) 2013-10-07
JP4030578B2 (ja) 2008-01-09
TW422838B (en) 2001-02-21
DE19532668A1 (de) 1997-03-06
HUP9802941A3 (en) 1999-10-28
EP0863880B1 (de) 2003-11-19
SK284868B6 (sk) 2006-01-05
EA199800271A1 (ru) 1998-10-29
BG102287A (en) 1998-09-30
NO980906L (no) 1998-03-02
GEP20022652B (en) 2002-03-25
EP0863880A1 (de) 1998-09-16
UA46790C2 (uk) 2002-06-17
HUP9802941A2 (hu) 1999-09-28
AR003502A1 (es) 1998-08-05
HK1015776A1 (en) 1999-10-22
LT98047A (en) 1998-10-26
CA2184871A1 (en) 1997-03-06
EE9800063A (et) 1998-08-17
AU6737596A (en) 1997-03-27
CZ66198A3 (cs) 1998-07-15
PT863880E (pt) 2004-04-30
DE59610827D1 (de) 2003-12-24
FR13C0049I2 (fr) 2014-03-28
JPH11512101A (ja) 1999-10-19
BR9610359A (pt) 1999-07-06
AU700602B2 (en) 1999-01-07
CA2184871C (en) 2001-08-21
HU225956B1 (en) 2008-01-28
EA000535B1 (ru) 1999-10-28
ZA967014B (en) 1997-08-18
SK21698A3 (en) 1998-10-07
LT4482B (lt) 1999-03-25
NO980906D0 (no) 1998-03-02
FR13C0049I1 (enExample) 2013-09-27
NO313829B1 (no) 2002-12-09
PL188287B1 (pl) 2005-01-31
ES2208758T3 (es) 2004-06-16
CN1200728A (zh) 1998-12-02
IL123333A0 (en) 1998-09-24
WO1997009314A1 (de) 1997-03-13
NZ315624A (en) 1998-11-25
CZ291839B6 (cs) 2003-06-18
PL325413A1 (en) 1998-07-20
IL123333A (en) 2001-10-31

Similar Documents

Publication Publication Date Title
NO982404L (no) 1-(1,2-disubstituert piperidinyl)-4-substituert piperidinderivater som tachykinin reseptorantagonister
NO964700D0 (no) Nye aminosyrederivater, fremgangsmåte til deres fremstilling og farmasöytiske blandinger som inneholder disse forbindelser
NO20002787L (no) Nye forbindelser
NO20005454L (no) Nye hydroksyindoler, deres anvendelse som fosfodiesterase 4 inhibitorer og fremgangsmåte for fremstilling derav
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
ATE201872T1 (de) Kristallines hydrochlorid von (r)-(-)-2-(n-(4-(1, 1-dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl) butyl)-aminomethyl)-chroman
DK1032555T3 (da) Cykliske aminosyrer og derivater deraf, som er anvendelige som lægemidler
DK0736130T3 (da) Fremgangsmåde til at hindre, at gashydrater tilpropper ledninger
DK0676409T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK0858440T3 (da) Fremgangsmåde til fremstilling af 1,1,1,3,3-pentafluorpropan
DK0885234T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
AR004368A1 (es) Compuestos de piperidina -1,-4 sustituida, procedimientos para prepararlos y un procedimiento para preparar 1-bencil-4-((5,6-dimetoxi-1-indanon)-2-il)metilpiperidina mediante dichos compuestos.
DK0863880T3 (da) Nye, anti-konvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som indeholder en disubstitueret aminrest i 4-stilling, og fremgangsmåde til deres fremstilling
DK1015421T3 (da) Nye phenylamidinderivater, fremgangsmåder til deres fremstilling og deres anvendelse som lægemidler
NO304828B1 (no) Nye cykliske aminosyrer og derivater derav, fremgangsmÕte til deres fremstilling samt mellomprodukt
DK0838469T3 (da) 10,13,15-trioxatricyclo(9.2.1 9.6)-pentadecanon-derivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser
DK0906326T3 (da) Nye aromatiske derivater substitueret med en ribose, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ITVI910109A0 (it) Regolatore di pressione per gas.
DK0946579T3 (da) Nye forbindelser afledt af erythromcin, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DE60234394D1 (de) Aktivierung von speicherredundanz während des testens
NO20000199L (no) Medikamenter inneholdende polyhydroksybutylpyraziner, nye polyhydroksybutylpyraziner og deres fremstilling
DK0820440T3 (da) Hidtil ukendte carbamatforbindelser, som har en N-substitueret thiocarbamoylgruppe, og fremgangsmåde til deres fremstilling
DK191290D0 (da) Extracellulaer exopolymer, fremgangsmaade til fremstilling af samme og farmaceutiske praeparater indeholdende exopolymeren
DK0670020T3 (da) Holdeelement til trykledningsforbindelser
DK120889A (da) 3-(2,3,4,5,6-pentafluorphenoxy)-8-azabicyclooe3.2.1aaoctaner, en fremgangsmaade til deres fremstilling og deres anvendelse som medikamenter